SCPI Merck Sharp Dohme Pharma Tbk.

COMPANY REPORT : JANUARY 2019 As of 31 January 2019

Development Board Individual Index : 227.451
Industry Sector : Consumer Goods Industry (5) Listed Shares : 3,600,000
Industry Sub Sector : Pharmaceuticals (53) Market Capitalization : 104,400,000,000
584 | 0.10T | 0.001% | 99.97%

618 | - T | 0.00000% | 100.00000%

COMPANY HISTORY SHAREHOLDERS (December 2018)

Established Date : 07-Mar-1972 1. Schering-Plough Int. Inc. 2,325,350 : 64.59%
Listing Date : 08-Jun-1990 (IPO Price: 12,750) 2. Merck Sharp & Dohme Corp. (MSD Corp.) 1,228,186 : 34.12%
Underwriter IPO : 3. Public (<5%) 46,464 : 1.29%
PT Inter-Pacific Securities
PT Jardine Fleming Nusantara DIVIDEND ANNOUNCEMENT
PT Wardley James C.I Bonus Cash Recording Payment
F/I
Securities Administration Bureau : Year Shares Dividend Cum Date Ex Date Date Date
PT Ficomindo Buana Registrar 1990 140.00 16-Jul-91 17-Jul-91 24-Jul-91 19-Aug-91 F
1991 100.00 17-Jun-92 18-Jun-92 25-Jun-92 25-Jul-92 F
BOARD OF COMMISSIONERS 1992 250.00 15-Jul-93 16-Jul-93 23-Jul-93 23-Aug-93 F
1. Dorthe Mikkelsen 1993 350.00 22-Jul-94 25-Jul-94 1-Aug-94 31-Aug-94 F
2. Christoper Patrick Mcnamara 1994 600.00 24-Jul-95 25-Jul-95 2-Aug-95 31-Aug-95 F
3. Irsan Budianto Darmadji *) 1995 750.00 23-Jul-96 24-Jul-96 1-Aug-96 30-Aug-96 F
*) Independent Commissioners 1996 510.00 2-Jul-97 3-Jul-97 11-Jul-97 9-Aug-97 F
1997 510.00 22-Jun-98 23-Jun-98 1-Jul-98 30-Jul-98 F
BOARD OF DIRECTORS
1. Ashish Pal ISSUED HISTORY
2. Akert Kasey Ann Listing Trading
3. Erwin Agung No. Type of Listing Shares Date Date
4. Novian Zein 1. First Issue 892,800 8-Jun-90 8-Jun-90
2. Partial Listing 187,200 25-Aug-94 25-Aug-94
AUDIT COMMITTEE 3. Company Listing 2,520,000 5-Jan-01 5-Jan-01
1. Irsan Budianto Darmadji
2. Muhammad Fakhruddin
3. Ngakan Putu Adhiriana

CORPORATE SECRETARY
Erwin Agung

HEAD OFFICE
Wisma BNI 46, 27th floor
Jl. [Link] Kav. 1
Jakarta 10220
Phone : (021) 5789-7000
Fax : (021) 5789-7099
Homepage : [Link]
Email :
 SCPI Merck Sharp Dohme Pharma Tbk.
TRADING ACTIVITIES
Closing Price* and Trading Volume
Merck Sharp Dohme Pharma Tbk. Closing Price Freq. Volume Value

Day
Closing Volume
Price* January 2015 - January 2019 (Mill. Sh) Month High Low Close (X) (Thou. Sh.) (Million Rp)
30,000 0.02 Jan-15 - - 29,000 - - - -
Feb-15 - - 29,000 - - - -
26,250 0.01 Mar-15 - - 29,000 - - - -
Apr-15 - - 29,000 - - - -
May-15 - - 29,000 - - - -
22,500 0.01
Jun-15 - - 29,000 - - - -
Jul-15 - - 29,000 - - - -
18,750 0.01
Aug-15 - - 29,000 - - - -
Sep-15 - - 29,000 - - - -
15,000 0.01
Oct-15 - - 29,000 - - - -
Nov-15 - - 29,000 - - - -
11,250 0.01 Dec-15 - - 29,000 - - - -

7,500 0.00 Jan-16 - - 29,000 - - - -

Feb-16 - - 29,000 - - - -
3,750 0.00 Mar-16 - - 29,000 - - - -
Apr-16 - - 29,000 - - - -
May-16 - - 29,000 - - - -
Jun-16 - - 29,000 1 11 1,090 1
Jan-15 Jan-16 Jan-17 Jan-18 Jan-19
Jul-16 - - 29,000 - - - -
Aug-16 - - 29,000 - - - -
Sep-16 - - 29,000 - - - -
Closing Price*, Jakarta Composite Index (IHSG) and Oct-16 - - 29,000 - - - -
Consumer Goods Industry Index Nov-16 - - 29,000 - - - -
January 2015 - January 2019 Dec-16 - - 29,000 - - - -
50%
Jan-17 - - 29,000 - - - -
40% Feb-17 - - 29,000 - - - -
Mar-17 - - 29,000 - - - -
30% Apr-17 - - 29,000 - - - -
24.6%
May-17 - - 29,000 - - - -
20% 20.7% Jun-17 - - 29,000 - - - -
Jul-17 - - 29,000 - - - -
Aug-17 - - 29,000 - - - -
10%
Sep-17 - - 29,000 - - - -
Oct-17 - - 29,000 - - - -
- 0.0%
Nov-17 - - 29,000 - - - -
Dec-17 - - 29,000 - - - -
-10%

Jan-18 - - 29,000 - - - -
-20% Feb-18 - - 29,000 - - - -
Mar-18 - - 29,000 - - - -
-30% Apr-18 - - 29,000 - - - -
Jan 15 Jan 16 Jan 17 Jan 18 Jan 19 May-18 - - 29,000 - - - -
Jun-18 - - 29,000 - - - -
Jul-18 - - 29,000 - - - -
SHARES TRADED 2015 2016 2017 2018 Jan-19 Aug-18 - - 29,000 - - - -
Volume (Million Sh.) - 0.01 - - - Sep-18 - - 29,000 - - - -
Value (Billion Rp) - 1 - - - Oct-18 - - 29,000 - - - -
Frequency (Thou. X) - 0.001 - - - Nov-18 - - 29,000 - - - -
Days - 1 - - - Dec-18 - - 29,000 - - - -

Price (Rupiah) Jan-19 - - 29,000 - - - -

High - - - - -
Low - - - - -
Close 29,000 29,000 29,000 29,000 29,000
Close* 29,000 29,000 29,000 29,000 29,000

PER (X) 0.75 0.45 0.58 0.84 0.84

PER Industry (X) 17.71 23.77 18.48 24.94 36.52
PBV (X) 1.03 0.38 0.28 0.23 0.23
* Adjusted price after corporate action
 SCPI Merck Sharp Dohme Pharma Tbk.
Financial Data and Ratios Book End : December
Public Accountant : Tanudiredja, Wibisana, Rintis, & Partners

BALANCE SHEET Dec-14 Dec-15 Dec-16 Dec-17 Sep-18 TOTAL ASSETS AND LIABILITIES (Bill. Rp)
(in Million Rp, except Par Value) Assets Liabilities
Cash & Cash Equivalents 35,470 9,201 68,229 22,097 29,594 1,625

Receivables 568,017 566,688 304,648 336,363 345,353

324,082 407,900 388,137 347,357 476,934 1,300
Inventories
Current Assets 1,052,937 1,261,501 1,144,724 1,098,245 1,323,127
975
Fixed Assets 247,072 238,683 234,101 244,203 271,245
Other Assets 1,070 100 130 116 109
650
Total Assets 1,317,315 1,510,748 1,393,084 1,354,104 1,606,837
Growth (%) 14.68% -7.79% -2.80% 18.66% 325

Current Liabilities 429,723 989,115 214,416 848,450 800,130 -

Long Term Liabilities 931,448 420,761 944,399 148,504 334,993 2014 2015 2016 2017 Sep-18
Total Liabilities 1,361,172 1,409,876 1,158,815 996,954 1,135,123
Growth (%) 3.58% -17.81% -13.97% 13.86%
TOTAL EQUITY (Bill. Rp)
Authorized Capital 5,000 5,000 5,000 5,000 5,000 472
Paid up Capital 3,600 3,600 3,600 3,600 3,600,000 472

Paid up Capital (Shares) 4 4 4 4 3,600 357

Par Value 1,000 1,000 1,000 1,000 1,000
369

Retained Earnings -111,165 33,564 61,636 288,489 403,053

234
-43,857 100,872 234,269 357,150 471,714
265

Total Equity
Growth (%) N/A 132.24% 52.45% 32.08%
101
162

INCOME STATEMENTS Dec-14 Dec-15 Dec-16 Dec-17 Sep-18 59

2014
Total Revenues 965,818 2,260,572 2,399,835 2,184,624 1,089,776
Growth (%) 134.06% 6.16% -8.97% 2015 2016 2017 Sep-18
-44

-44

Cost of Revenues 861,652 1,837,376 2,010,906 1,855,951 914,469

Gross Profit 104,166 423,196 388,929 328,673 175,307
TOTAL REVENUES (Bill. Rp)
Expenses (Income) - 224,825 165,854 148,031 22,558
Operating Profit - - - 180,642 152,749 2,400
2,261 2,185
Growth (%)
2,400

1,910

Other Income (Expenses) -174,926 - - - -

Income before Tax -70,760 198,370 223,074 180,642 152,749 1,421

1,090
Tax 8,298 59,049 88,347 58,127 38,185 966
Profit for the period -62,461 139,322 134,727 122,515 114,564 931

Growth (%) N/A -3.30% -9.06%

442

Period Attributable -62,461 139,322 134,727 122,515 114,564 -48

Comprehensive Income -62,461 144,729 133,397 121,529 114,564 2014 2015 2016 2017 Sep-18
Comprehensive Attributable -62,461 144,729 133,397 121,529 114,564

RATIOS Dec-14 Dec-15 Dec-16 Dec-17 Sep-18 PROFIT FOR THE PERIOD (Bill. Rp)
Current Ratio (%) 245.03 127.54 533.88 129.44 165.36
139 135
Dividend (Rp) - - - - - 123
115
139

EPS (Rp) -17,350.39 38,700.47 37,424.24 34,031.95 31.82

BV (Rp) -12,182.44 28,020.03 65,074.67 99,208.36 131.03 99

DAR (X) 1.03 0.93 0.83 0.74 0.71

DER(X) -31.04 13.98 4.95 2.79 2.41
59

ROA (%) -4.74 9.22 9.67 9.05 7.13 18

2014
ROE (%) 142.42 138.12 57.51 34.30 24.29
GPM (%) 10.79 18.72 16.21 15.04 16.09 -22
2015 2016 2017 Sep-18
OPM (%) - - - 8.27 14.02
NPM (%) -6.47 6.16 5.61 5.61 10.51
-62

-62
Payout Ratio (%) - - - - -
Yield (%) - - - - -

*US$ Rate (BI), Rp 12,436 13,794 13,436 13,548 14,929